B. Ke

Compromised in Patients with Mild Alzheimer Disease Brain Barrier , Is −-Amyloid Transporter at the Blood β Activity of P-Glycoprotein , a

F. O’Sullivan, S. Borson, S. Minoshima, 2014 .

The Impact of the BBB on the Pharmacokinetics of Drugs: Investigations by PET

J. Unadkat, S. Eyal, B. Ke, 2012 .

Regional P‐Glycoprotein Activity and Inhibition at the Human Blood–Brain Barrier as Imaged by Positron Emission Tomography

D. Mankoff, A. Collier, M. Muzi, 2010, Clinical pharmacology and therapeutics.

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

F. O’Sullivan, D. Mankoff, S. Borson, 2014, The Journal of Nuclear Medicine.

Doc2β Is a Novel Munc18c-interacting Partner and Positive Effector of Syntaxin 4-mediated Exocytosis*

B. Ke, Eunjin Oh, D. Thurmond, 2007, Journal of Biological Chemistry.

The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes

C. Endres, J. Unadkat, D. Choi, 2009, Journal of Pharmacology and Experimental Therapeutics.